TM4SF5 and cancer: Here, we isolated a novel monoclonal antibody targeting a structural epitope of TM4SF5, a protein that induces EMT, proliferation, and metastasis in cancer, and evaluated TM4SF5 as a target of immunotherapy to suppress metastasis of colon cancer in a mouse model.